Viridian Therapeutics, Inc.\DE ($VRDN)
Tousignant Jennifer โ Chief Legal Officer
Shares
23,850
Price
$0.00
Total Value
$0.00
Nearby Earnings
Feb 26, 2026
EPS:Est: -0.88
Transaction Details
| Insider | Tousignant Jennifer |
|---|---|
| Title | Chief Legal Officer |
| Transaction Date | Mar 2, 2026 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Restricted Stock Units |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Mar 5, 2026 |
| Shares Purchased | 23,850 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 23,850 |
| Derivative | Derivative |
| Accession Number | 0001193125-26-092074 |
| Document | View SEC Filing |